Printer Friendly

Canadian partnership hopes to drive mass production of stem cells.

TORONTO, Ont., August 23,2012 -- Stem cells hold great promise for treating and curing numerous diseases; however, a major challenge facing scientists is how to produce stem cells in the massive quantities required for clinical use.

The McEwen Centre for Regenerative Medicine (McEwen Centre) and the Centre for Commercialization of Regenerative Medicine (CCRM) are partnering to establish a fund that will drive research in this area.

The McEwen Centre-CCRM Commercialization Impact Prize will solicit innovative ideas from regenerative medicine scientists working in labs throughout the McEwen Centre. The winning team(s) will be awarded up to $600,000 to pursue research that will determine how to manufacture stem cells for clinical use and drug screening.

"This private-public funding partnership is an important step forward to accelerating the advance of a discovery from a lab bench to the patient and onto the global market. Scientists at the McEwen Centre are making significant progress towards finding a cure for diseases such as Type 1 diabetes and heart disease. Collaborative partnerships are the key to discovering the cures sooner!" says Rob McEwen, co-founder of the McEwen Centre, and chief owner of McEwen Mining.

Deadline for submissions is October 15, 2012. The Prize will fund up to two, 2-year projects that address the following challenges:

--Making the transition from pre-clinical to clinical mass production

--Scaling up stem cell manufacturing for high throughput drug screening

"Overcoming the scale-up and manufacturing challenge of stem cells would be a huge advancement for the regenerative medicine (RM) industry and this initiative fits in perfectly with our mandate to bridge the RM commercialization gap," explains Dr. Michael May, CEO of the Centre for Commercialization of Regenerative Medicine. "We're very pleased to be working with the McEwen Centre, already a partner of ours, to make this happen."

Contact: The Commercialization Impact Prize budget template and application form can be found at http://

COPYRIGHT 2012 DataTrends Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Strategic & Research Alliances
Publication:Stem Cell Lab World
Date:Sep 10, 2012
Previous Article:Stemedica international licenses stemedyne stem cell line.
Next Article:Taconic, CLEA to produce and distribute animal models.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters